Lucent Drugs Pvt. Ltd. Vs Deputy Director (Appellate Tribunal under SAFEMA, New Delhi)
Export NOC Cannot Shield Deliberate Diversion to an Unauthorised Destination: PMLA Attachment Upheld
Background of the Dispute
The appeal arose from the attachment of property representing the alleged proceeds of crime of ₹5,46,58,871. The company challenged the Adjudicating Authority’s order dated 25 July 2025, confirming the provisional attachment dated 19 February 2025.
The proceedings originated from an investigation by the Narcotics Control Bureau into alleged violations involving controlled substances and the export of Tramadol. The allegations included stock discrepancies in acetic anhydride, failure to submit prescribed returns and maintain statutory records, and exports ultimately destined for Pakistan through overseas intermediaries.
Following the complaint under the NDPS Act, the Enforcement Directorate registered an ECIR on 29 December 2023. Its investigation relied on statements recorded under section 50 of the PMLA, commercial documents and electronic correspondence.
Company’s Defence: Exports Were Covered by Valid NOCs
The appellant contended that the Central Bureau of Narcotics had issued valid No Objection Certificates for exports to the foreign purchasers and destinations mentioned in its applications.
According to the company, direct exports to Pakistan had earlier been permitted, but no direct export was undertaken after permission ceased. Subsequent exports were made to buyers in countries such as Denmark and Malaysia. If those purchasers independently resold or re-exported the goods to Pakistan, the appellant argued, responsibility could not be attributed to the Indian exporter.
Want to Read the Complete Judgment?
You have read the free case summary. Unlock the full judgment, the detailed judicial reasoning and the downloadable PDF, along with every other premium judgment on TaxGuru.
Already subscribed? Log in
One subscription covers the entire premium judgment library, not just this case.





